Contributors:
Insights to help you protect your heart:
In this episode, Medcan Chief Medical Officer Dr. Peter Nord sits down with our Clinical Director of Cardiology, Dr. Beth Abramson to explore the advancements and best practices in proactive heart health testing. With 9 in 10 Canadians having at least one risk factor for heart disease, this is a topic that impacts everyone.
In this episode, you'll learn:
- Why proactive screening matters and why heart disease is often referred to 'the silent killer,' along with who should be screened, when, and why
- What screenings are recommended as the 'gold standard' in proactive testing to identify signs of disease or heart attack and stroke before they happen
- The specific tests that you should consider as part of a proactive approach to heart health, including hs-troponin, ECG, carotid medial thickness, and the new heart health tests Lp(a) and APOB - both now included in the Medcan Annual Health Assessment.
- What the evidence and research shows us about how these tests work and the type of outcomes we can expect.
- How the knowledge from you screening results can empower you to take action that could add years to your life and improve your long-term wellbeing.
We hope this episode will inspire you to take proactive care of your heart! To take action today, learn more about Medcan's Annual Health Assessment or Enhanced Heart Health Assessment, linked below.
Note: This information is intended for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment.
Dr. Peter NordChief Medical OfficerDr. Peter Nord is the Chief Medical Officer (CMO) at Medcan Health Management Inc. (Medcan), with accountability for all clinical activities across the organization.
